Antiviral activity of theaflavin digallate against herpes simplex virus type 1

Antiviral Research

Volumn 118, Issue , 2015, Pages 56-67

  De Oliveira, Aline ^a   Prince, Derek ^a   Lo, Chih Yu ^b   Lee, Lee H ^c   Chu, Tin Chun ^a  

^a SETON HALL UNIVERSITY   (United States)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^c MONTCLAIR STATE UNIVERSITY   (United States)

Author keywords

A549 cells; Herpes simplex virus; HSV 1; Natural product; Theaflavins; Vero cells

Indexed keywords

ANTIVIRUS AGENT; CATECHIN; DEUTERIUM; POLYPHENOL; THEAFLAVIN; THEAFLAVIN 3 MONOGALLATE; THEAFLAVIN 3' MONOGALLATE; THEAFLAVIN 3,3' DIGALLATE; UNCLASSIFIED DRUG; BIFLAVONOID; BIOLOGICAL PRODUCT; DISINFECTANT AGENT; GALLIC ACID; THEAFLAVIN DIGALLATE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING ASSAY; CELL CULTURE; CELL STRUCTURE; CHLOROCEBUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG STRUCTURE; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MTS ASSAY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; TEA; VERO CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; CAMELLIA SINENSIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EPITHELIUM CELL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PHYSIOLOGY; STAINING; VIRAL PLAQUE ASSAY; VIRUS INACTIVATION;

CAMELLIA SINENSIS; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

ANIMALS; BIFLAVONOIDS; BIOLOGICAL PRODUCTS; CAMELLIA SINENSIS; CATECHIN; CELL LINE; CELL SURVIVAL; DISINFECTANTS; EPITHELIAL CELLS; FLOW CYTOMETRY; GALLIC ACID; HERPESVIRUS 1, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; STAINING AND LABELING; VIRAL PLAQUE ASSAY; VIRUS INACTIVATION;

EID: 84926197774     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.03.009     Document Type: Article

References (32)

1. M.P. Almajano, Rosa Carbó, J.A.L. Jimenez, and M.H. Gordon Antioxidant and antimicrobial activities of tea infusions Food Chem. 108 2008 55 63
2. T.H. Bacon, M.J. Levin, J.J. Leary, R.T. Sarisky, and D. Sutton Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy Clin. Microbiol. Rev. 16 2003 114 128
3. D.I. Bernstein, and L.R. Stanberry Herpes simplex virus vaccines Vaccine 17 1999 1681 1689
4. R.C. Brady, and D.I. Bernstein Treatment of herpes simplex virus infections Antiviral Res. 61 2004 73 81
5. A. Cantatore, S.D. Randall, D. Traum, and S.D. Adams Effect of black tea extract on herpes simplex virus-1 infection of cultured cells BMC Complem. Altern. Med. 13 2013 139
6. L.C. Chiang, W. Chiang, M.Y. Chang, L.T. Ng, and C.C. Lin Antiviral activity of Plantago major extracts and related compounds in vitro Antiviral Res. 55 2002 53 62
7. K.J. Clark, P.G. Grant, A.B. Sarr, J.R. Belakere, C.L. Swaggerty, T.D. Phillips, and G.N. Woode An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections Vet. Microbiol. 63 1998 147 157
8. A. de Oliveira, S.D. Adams, L.H. Lee, S.R. Murray, S.D. Hsu, J.R. Hammond, D. Dickinson, P. Chen, and T.C. Chu Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate Food Chem. Toxicol. 52 2013 207 215
9. A. Dolan, F.E. Jamieson, C. Cunningham, B.C. Barnett, and D.J. McGeoch The genome sequence of herpes simplex virus type 2 J. Virol. 72 1998 2010 2021
10. C.J. Dufresne, and E.R. Farnworth A review of latest research findings on the health promotion properties of tea J. Nutr. Biochem. 12 2001 404 421
11. M. Fatahzadeh, and R.A. Schwartz Human herpes simplex labialis Clin. Exp. Dermatol. 32 2007 625 630
12. M. Friedman Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas Mol. Nutr. Food Res. 51 2007 116 134
13. J.A. Garner Herpes simplex virion entry into and intracellular transport within mammalian cells Adv. Drug Deliv. Rev. 55 2003 1497 1513
14. A. Gosslau, D.L. En Jao, M.T. Huang, C.T. Ho, D. Evans, N.E. Rawson, and K.Y. Chen Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo Mol. Nutr. Food Res. 55 2011 198 208
15. C.E. Isaacs, and W. Xu Theaflavin-3,3′-digallate and lactic acid combinations reduce herpes simplex virus infectivity Antimicrob. Agents Chemother. 57 2013 3806 3814
16. C.E. Isaacs, W. Xu, G. Merz, S. Hillier, L. Rohan, and G.Y. Wen Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus Antimicrob. Agents Chemother. 55 2011 5646 5653
17. S.A. Jassim, and M.A. Naji Novel antiviral agents: a medicinal plant perspective J. Appl. Microbiol. 95 2003 412 427
18. J.W. Jhoo, C.Y. Lo, S. Li, S. Sang, C.Y. Ang, T.M. Heinze, and C.T. Ho Stability of black tea polyphenol, theaflavin, and identification of theanaphthoquinone as its major radical reaction product J. Agric. Food Chem. 53 2005 6146 6150
19. M.F. Kramer, W.J. Cook, F.P. Roth, J. Zhu, H. Holman, D.M. Knipe, and D.M. Coen Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression J. Virol. 77 2003 9533 9541
20. Y. Kuroda, and Y. Hara Antimutagenic and anticarcinogenic activity of tea polyphenols Mutat. Res. 436 1999 69 97
21. S. Li, C.Y. Lo, M.H. Pan, C.S. Lai, and C.T. Ho Black tea: chemical analysis and stability Food Funct. 4 2013 10 18
22. S. Liu, H. Lu, Q. Zhao, Y. He, J. Niu, A.K. Debnath, S. Wu, and S. Jiang Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 Biochim. Biophys. Acta 1723 2005 270 281
23. C.Y. Lo, S. Li, D. Tan, M.H. Pan, S. Sang, and C.T. Ho Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions Mol. Nutr. Food Res. 50 2006 1118 1128
24. M.A. Murphy, M.A. Bucks, K.J. O'Regan, and R.J. Courtney The HSV-1 tegument protein pUL46 associates with cellular membranes and viral capsids Virology 376 2008 279 289
25. J. Piret, and G. Boivin Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management Antimicrob. Agents Chemother. 55 2011 459 472
26. D.C. Quenelle, D.J. Collins, D.J. Marciani, and E.R. Kern Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2 Vaccine 24 2006 1515 1522
27. A.B. Sharangi Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) - a review Food Res. Int. 42 2008 529 535
28. P.G. Spear, S. Manoj, M. Yoon, C.R. Jogger, A. Zago, and D. Myscofski Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry Virology 344 2006 17 24
29. R.P. Subramanian, and R.J. Geraghty Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B Proc. Natl. Acad. Sci. U.S.A. 104 2007 2903 2908
30. M. Willard Rapid directional translocations in virus replication J. Virol. 76 2002 5220 5232
31. J. Yang, L. Li, S. Tan, H. Jin, J. Qiu, Q. Mao, R. Li, C. Xia, Z.H. Jiang, S. Jiang, and S. Liu A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection Fitoterapia 83 2012 348 355
32. M. Zu, F. Yang, W. Zhou, A. Liu, G. Du, and L. Zheng In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives Antiviral Res. 94 2012 217 224